Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Coeur Mining Clears Major Acquisition Hurdle Amid Silver Surge

Robert Sasse by Robert Sasse
January 15, 2026
in Analysis, Commodities, Mergers & Acquisitions
0
Coeur Mining Stock
0
SHARES
17
VIEWS
Share on FacebookShare on Twitter

Shares of Coeur Mining are trading near their annual peak, buoyed by a confluence of favorable market conditions. The company is advancing toward creating a new industry heavyweight, having secured a critical endorsement for its planned acquisition of New Gold from the influential proxy advisor Institutional Shareholder Services (ISS). This development coincides with silver prices reaching unprecedented highs, creating a potent catalyst for the miner’s stock.

Silver Market Provides Powerful Tailwind

The broader commodity landscape is delivering significant momentum. For the first time in history, the price of silver has breached the $90 per ounce threshold, trading around $92 per ounce on Wednesday morning. Market analysts attribute this rally to a tightening supply picture, exacerbated by Chinese export restrictions on refined silver, coupled with sustained robust industrial demand from the solar panel and electronics manufacturing sectors.

This bullish environment for the underlying metal is reflected in Coeur’s equity performance. The stock, currently priced at $21.28, is trading just shy of its 52-week high of $21.61. Over a twelve-month period, the share price has delivered a remarkable gain exceeding 242 percent.

Key Endorsement for New Gold Deal

A pivotal milestone has been reached in Coeur’s expansion strategy. ISS has advised shareholders of New Gold to vote in favor of the acquisition by Coeur Mining. On Wall Street, such a recommendation from a leading proxy advisory firm is viewed as a strong indicator for the outcome of the shareholder vote, which is scheduled for January 27, 2026.

Should investors sell immediately? Or is it worth buying Coeur Mining?

ISS evaluated the transaction as “strategically sound,” citing the operational synergies, stronger balance sheet, and improved liquidity that the combined entity would achieve. The scale of the deal is substantial: the merged company is projected to generate approximately $3 billion in EBITDA for 2026—a significant increase from the $1 billion forecast for Coeur on a standalone basis. Under the terms, New Gold shareholders would receive 0.4959 Coeur shares for each of their shares, giving them a 38 percent stake in the newly formed mining group.

Analyst Sentiment Remains Favorable

Given these fundamental developments, the analyst community maintains a constructive outlook. The majority of the eleven firms covering the stock rate it as a “Buy” or “Strong Buy.” Recently, Roth Capital raised its price target from $20 to $23. The average analyst price target stands at $16.75, although the recent share price rally has already surpassed some of these valuations.

Forthcoming Catalysts

Investors are now focused on two key upcoming dates. The January 27, 2026, vote by New Gold shareholders will determine whether the acquisition proceeds. Should this hurdle be cleared as anticipated, attention will turn to February 18, 2026. After the market closes that day, Coeur Mining is set to report its fourth-quarter and full-year 2025 financial results and is expected to provide further details regarding the integration of New Gold.

Ad

Coeur Mining Stock: Buy or Sell?! New Coeur Mining Analysis from March 25 delivers the answer:

The latest Coeur Mining figures speak for themselves: Urgent action needed for Coeur Mining investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Coeur Mining: Buy or sell? Read more here...

Tags: Coeur Mining
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Next Post
Viking Therapeutics Stock

Viking Therapeutics Gains Momentum Following Key Industry Conference

SoftBank Stock

SoftBank's Strategic Pivot: A Multi-Billion Dollar Bet on AI Dominance

Cardano Stock

Cardano's Quiet Consolidation Hints at Underlying Strength

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com